04rbi-8.qxp

ARTICLE II
Under the Rules of the International Association of Athletics Federations(IAAF) and the Operating Regulations of USATF, doping is strictly forbidden.
The governing provisions are those of IAAF Rules 30-45 and USATFRegulation 10. This Rule 32 is intended only as a helpful summary of thoseprovisions and not as an official source. The following are guilty of a doping offense: (a) An athlete whose body tissues or fluids are found to contain a prohibited (b) An athlete who uses or takes advantage of a prohibited technique, (c) An athlete who admits having used or taken advantage of a prohibited sub- (d) An athlete who fails or refuses to submit to doping control after having (e) A person who assists or incites an athlete to use a prohibited substance or a (f ) A person who in any way improperly interferes with the collection, ship- ment, storing or testing of a sample, or with the administration of USATF'sor the IAAF's doping control regulations, and (g) An athlete who competes while ineligible to compete because of a doping The list of prohibited substances is included in the IAAF's ProceduralGuidelines for Doping Control. That list may be amended from time to time.
Metabolites of prohibited substances are also prohibited. As of January 1, 2007,the list includes the following substances: (a) Stimulants: e.g. adrafinil, adrenaline, amfepramone, amiphenazole, amphetamine, amphetaminil, benzphetamine, benzylpiperazine, broman-tan, carphedon (4-phenylpiracetam), cathine*, clobenzorex, cocaine,dimethylamphetamine, ephedrine*, etilamphetamine, etilefrine, famprofa-zone, fencamfamin, fencamine, fenetylline, fenfluramine, fenproporex, fur- 2008 USATF Competition Rules • 36
fenorex, mefenorex, mephentermine, mesocarb, methamphetamine,methylamphetamine, methylenedioxyamphetamine, methylene-dioxymethamphetamine, methylephedrine**, methylphenidate, modafinil,nikethamide, morfenfluramine, parahydroxyamphetamine, pemoline,phendimetrazine, phemetrazine, phentermine, prolintane, selegiline,strychnine, tuaminoheptane, and other substances with similar chemicalstructure or similar biological effects.
(b) Narcotic Analgesics: e.g., buprenorphine, dextromoramide, diamorphine (heroin), fentanyl and its derivatives, hydromorphine, methadone, mor-phine, oxycodone, pentazocine, and pethidine.
(c) Cannabinoids (e.g. hashish, marijuana).
(d) Steroids and anabolic agents: e.g., androstenediol, 1-androstenedione, bolandiol, bolasterone, boldenone, boldione, calusterone, clenbuterol,clostebol, danazol, dehydrochlormethyltestosterone, dehydroepiandros-terone (DHEA), desoxymethyltestosterone, dihydrotestosterone,drostanolone, ethylestrenol, fluoxymesterone, formebolone, furazabol,gestrinone, 4-hydroxytestosterone, 4-hydroxy-19-nortestosterone, mes-tanolone, mesterolone, methandienone, metenolone, methandriol, methyl-dienolone, methyltestosterone, methylnortestosterone, methyl-trienolone,mibolerone, nandrolone, 19-norandrostendiol, 19-norandrostendione,norbolethone, norclostebol, norethandrolone, oxabolone, oxandrolone,oxymesterone, oxymetholone, prasterone, prostanozol, quinbolone,stanozolol, stenbolone, 1-testosterone, tetrahydrogestrinone, tibolone,trenbolone, zeranol, zilpaterol, and other substances with a similar chemi-cal structure or similar biological effect(s).
(e) Peptide Hormones, Mimetics, and analogs: e.g., Corticotrophin (ACTH), Glucocorticosteroids**, Gonadotrophins*** (LH, HCG), GrowthHormone (hGH, somatotrophin), Erythropoietin (EPO) and other ery-thropoiesis-stimulating proteins (e.g. NESP, Nynepo), Mechano growthfactors (MGFs), Insulin-like Growth Factor (IGF-1), Insulin*****, and allrespective releasing factors of these substances. (f ) Anti-Estrogenic agents including Aromatase inhibitors, clomiphene, cyclofenil, Estrogen Receptor Modulators (SERMs), and tamoxifen areprohibited.
(g) Diuretics and other masking agents: e.g., probenecid and chemically or pharmacologically related compounds. Also many diuretics. *Cathine is prohibited when its concentration in urine is greater than 5 micro-grams per milliliter. For ephedrine and methylephedrine, the definition of a pos- 2008 USATF Competition Rules • 37
itive finding is one in which the concentration in urine exceeds 10 microgramsper millilitre. For phenylpropanolamine and pseudoephedrine, the definition ofa positive finding is one in which the concentration in urine exceeds 25 micro-grams per millilitre.
** USATF and the IAAF may, on notification and medical recommendationprior to use, approve inhalation therapy and local or intraarticular injections ofcorticosteroids. and inhalation of certain beta-2 agonists. *** Circumstances under which samples will be deemed to be positive for dihy-drotestosterone, testosterone and HCG are described in Schedule 1 of theIAAF's Procedural Guidelines, which appears in the USATF GovernanceManual.
****The administration of certain beta agonists is permitted with the prior writ-ten authorization of USATF and/or the IAAF.
*****Permitted only to treat insulin-dependent diabetes, with written notifica-tion by an endocrinologist. (For exemption procedure, see Chapter 5 of theIAAF’s Procedural Guidelines.) This list is not exhaustive. Other substances may be banned by theInternational Olympic Committee (IOC) and the United States OlympicCommittee (USOC). Some other substances not listed here may be consideredto be banned because they are related to specifically banned substances. Athletesare urged to call the U.S. Anti-Doping Agency (USADA) Drug Reference Lineat 1-800-233-0393 before taking any medication and/or food supplement.
The IAAF Handbook and Procedural Guidelines for Doping Control are availableat www.iaaf.org. Other useful sites are: www.wada-ama.org and www.usanti-doping.org.
Prohibited techniques include the exogenous use of epitestosterone to alter theratio of testosterone to epitestosterone, blood doping, gene doping, and the useof substances (e.g., diuretics, probenecid, and related compounds) and methods(e.g., catheterization, urine substitution and/or tampering) that alter the integri-ty and validity of urine samples collected during doping control. Individuals who have committed doping offenses may be declared ineligible andmay lose medals won and records set subsequent to the offense. If the offenseis based on in-competition testing, prizes or appearance money earned at thatcompetition and subsequent competitions are subject to forfeiture.
USATF participates in out-of-competition and in-competition doping controlprograms conducted by various drug testing authorities. One program is con- 2008 USATF Competition Rules • 38
ducted by the United States Anti-Doping Agency (USADA) on behalf of theUnited States Olympic Committee (USOC). Another is conducted by IDTMon behalf of the International Association of Athletics Federations (IAAF). Onoccasion, USADA conducts testing on behalf of the IAAF. The IAAF has alsocontracted with the World Anti-Doping Agency (WADA) to conduct testing oftrack and field athletes on its behalf. Therefore, a USATF athlete may be drugtested by USADA, IDTM, or WADA. The relevant protocols are set forth inthe 2008 USATF Governance Handbook.
2008 USATF Competition Rules • 39

Source: http://www.hatterstrack.us/reference/2008USATFRules_Article2.pdf